TMCI icon

Treace Medical Concepts

7.05 USD
+0.15
2.17%
At close Apr 29, 4:00 PM EDT
After hours
7.05
+0.00
0.00%
1 day
2.17%
5 days
8.29%
1 month
-15.97%
3 months
-32.34%
6 months
46.27%
Year to date
-10.42%
1 year
-33.80%
5 years
-72.39%
10 years
-72.39%
 

About: Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Employees: 477

0
Funds holding %
of 7,425 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

736% more call options, than puts

Call options by funds: $1.21M | Put options by funds: $145K

22% more capital invested

Capital invested by funds: $228M [Q3] → $278M (+$50.2M) [Q4]

18% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 22

2% more funds holding

Funds holding: 132 [Q3] → 134 (+2) [Q4]

2% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 44

3.23% less ownership

Funds ownership: 63.11% [Q3] → 59.88% (-3.23%) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$8
13%
upside
Avg. target
$8
13%
upside
High target
$8
13%
upside

1 analyst rating

positive
0%
neutral
100%
negative
0%
Truist Securities
Richard Newitter
55% 1-year accuracy
28 / 51 met price target
13%upside
$8
Hold
Maintained
11 Apr 2025

Financial journalist opinion

Based on 151 articles about TMCI published over the past 30 days

Neutral
Accesswire
13 hours ago
Treace Medical Concepts, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before June 10, 2025 to Discuss Your Rights - TMCI
NEW YORK, NY / ACCESS Newswire / April 29, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=146096&wire=1 or contact Joseph E. Levi, Esq.
Treace Medical Concepts, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before June 10, 2025 to Discuss Your Rights - TMCI
Neutral
GlobeNewsWire
13 hours ago
ROSEN, A TOP RANKED LAW FIRM, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TMCI
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc. (NASDAQ: TMCI) between May 8, 2023 and May 7, 2024, both dates inclusive (the “Class Period”), of the important June 10, 2025 lead plaintiff deadline.
ROSEN, A TOP RANKED LAW FIRM, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TMCI
Neutral
Accesswire
17 hours ago
Treace Medical Concepts, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - TMCI
NEW YORK, NY / ACCESS Newswire / April 29, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=146041&wire=1 or contact Joseph E. Levi, Esq.
Treace Medical Concepts, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - TMCI
Neutral
Accesswire
17 hours ago
TMCI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Treace Medical Concepts, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESS Newswire / April 29, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Treace Medical Concepts, Inc. ("Treace Medical" or "the Company") (NASDAQ:TMCI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Treace Medical securities between May 8, 2023 and May 7, 2024, both dates inclusive (the "Class Period").
TMCI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Treace Medical Concepts, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Neutral
GlobeNewsWire
19 hours ago
Contact Levi & Korsinsky by June 10, 2025 Deadline to Join Class Action Against Treace Medical Concepts, Inc. (TMCI)
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc." or the "Company") (NASDAQ: TMCI) of a class action securities lawsuit.
Contact Levi & Korsinsky by June 10, 2025 Deadline to Join Class Action Against Treace Medical Concepts, Inc. (TMCI)
Neutral
Accesswire
20 hours ago
Treace Medical Concepts, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - TMCI
NEW YORK, NY / ACCESS Newswire / April 29, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=146022&wire=1 or contact Joseph E. Levi, Esq.
Treace Medical Concepts, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - TMCI
Neutral
Accesswire
21 hours ago
Levi & Korsinsky Notifies Treace Medical Concepts, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - TMCI
NEW YORK, NY / ACCESS Newswire / April 29, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=146008&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Notifies Treace Medical Concepts, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - TMCI
Neutral
GlobeNewsWire
21 hours ago
TMCI Investors Have the Opportunity to Lead the Treace Medical Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace Medical To Contact Him Directly To Discuss Their Options
TMCI Investors Have the Opportunity to Lead the Treace Medical Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Neutral
Accesswire
22 hours ago
June 10, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against TMCI
NEW YORK, NY / ACCESS Newswire / April 29, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=145996&wire=1 or contact Joseph E. Levi, Esq.
June 10, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against TMCI
Neutral
GlobeNewsWire
22 hours ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com  or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
Charts implemented using Lightweight Charts™